CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Anjali Bhardwaj - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Anjali Bhardwaj

OPENALEX: A5101685709↗ORCID: 0000-0002-3280-6688↗

Affiliations

Organizations

National Health and Medical Research Councilauthorship · AU South Eastern Sydney Local Health Districtauthorship · AU Sydney Local Health Districtauthorship · AU The University of Sydneyauthorship · AU

Public evidence

2 connected articles

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.2024 · Europe PMC Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.